Finally, arGLP-1 has been shown to improve the pre- and postprandial lipid profile, with a reduction in the levels of free fatty acids, triglycerides and LDL cholesterol, as well as the fraction of small and dense LDL and a reduction of the increase levels of triglycerides and apo-B48 postprandial.7882 Likewise, it has been reported a reduction in markers of inflammation, plasminogen activator inhibitor type 1 and leptin whereas adiponectin levels increase.47,48 Regarding the adverse effects of this family, the most important are gastrointestinal, especially nausea and vomiting of mild-moderate intensity, which are reduced with time
This means the body can still modulate output based on its needs
GLP-1 Medications GLP-1 medications have changed the conversation around weight management and type 2 diabetes
doi: 10.3389/fpsyt.2020.00763 40
Patients with type 2 diabetes either have trouble producing enough insulin or have become less sensitive to insulin
The practical upshot is that the anti-inflammatory effect seems to operate even at low doses what clinicians increasingly call microdosing, which Ill return to below